Stay updated on Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Sign up to get notified when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a general site release without altering the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-25T05:21:43.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Regional names Královéhradecký kraj and Olomoucký kraj were updated to Hradec Králové Region and Olomouc Region, respectively, with the corresponding addresses adjusted. The revision tag was updated to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:30:12.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Padova, Italy, 35128 and removed Padua, Italy, 35128 from the locations list.
    Difference
    0.0%
    Check dated 2026-04-03T18:43:42.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Napoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the locations section.
    Difference
    0.0%
    Check dated 2026-03-27T12:28:19.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-20T03:30:22.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T21:09:45.000Z thumbnail image

Stay in the know with updates to Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.